[CRVS] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
07-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 7.73%
YoY- 59.54%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 246 0 0 0 0 -
PBT -4,262 -5,701 -6,653 -6,000 -6,503 -7,873 -9,816 -42.68%
Tax 0 -20 -95 -425 -403 923 6,384 -
NP -4,262 -5,701 -6,653 -6,000 -6,503 -8,796 -16,200 -58.97%
Tax Rate - - - - - - - -
Total Cost 4,262 5,701 6,899 6,000 6,503 8,796 16,200 -58.97%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 -2,704.47 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.07 -0.12 -0.14 -0.12 -0.14 -0.19 -0.35 -65.83%
EPS Diluted -0.07 -0.12 -0.14 -0.12 -0.14 -0.19 -0.35 -65.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.